Sfoglia per AUTORE
FASSNACHT M
Collezione AOU San Luigi di Orbassano

  

Items : 20

International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. in European journal of endocrinology / Eur J Endocrinol. 2024 Mar 30;190(4):G15-G24. doi: 10.1093/ejendo/lvae038.
2024
AOU San Luigi di Orbassano

Riedmeier M; Antonini SRR; Brandalise S; Costa TEJB; Daiggi CM; de Figueiredo BC; de Krijger RR; De Sá Rodrigues KE; Deal C; Del Rivero J; Engstler G; Fassnacht M; Fernandes Luiz Canali GC; Molina CAF; Gonc EN; Gültekin M; Haak HR; Guran T; Hendriks Allaird EJ; Idkowiak J; Kuhlen M; Malkin D; Meena JP; Pamporaki C; Pinto E; Puglisi S; Ribeiro RC; Thompson LDR; Yalcin B; et alii...

2024
AOU San Luigi di Orbassano

Riedmeier M; Agarwal S; Antonini S; Costa TEIJB; Diclehan O; Fassnacht M; Figueiredo BC; Guran T; Härtel C; Haubitz I; Idkowiak J; Kuhlen M; Noronha L; Parise IZS; Redlich A; Puglisi S; Saniye E; Schlegel PG; Yalcin B; Wiegering V;

The Value of Local Therapies in Advanced Adrenocortical Carcinoma. in Cancers / Cancers (Basel). 2024 Feb 7;16(4):706. doi: 10.3390/cancers16040706.
2024
AOU San Luigi di Orbassano

Kimpel O; Altieri B; Laganà M; Vogl TJ; Adwan H; Dusek T; Basile V; Pittaway J; Dischinger U; Quinkler M; Kroiss M; Puglisi S; Cosentini D; Kickuth R; Kastelan D; Fassnacht M;

Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. in European journal of endocrinology / Eur J Endocrinol. 2023 Oct 17;189(4):S88-S101. doi: 10.1093/ejendo/lvad134.
2023
AOU San Luigi di Orbassano

Pelsma ICM; Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM;

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.
2023
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A; Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2022 Jul 19;187(3):R27-R40. doi: 10.1530/EJE-22-0260. Print 2022 Sep 1.
2022
AOU San Luigi di Orbassano

Terzolo M; Fassnacht M;

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. in British journal of cancer / Br J Cancer. 2021 Oct;125(9):1233-1238. doi: 10.1038/s41416-021-01513-8. Epub 2021 Aug 16.
2021
AOU San Luigi di Orbassano

Kimpel O; Bedrose S; Megerle F; Berruti A; Terzolo M; Kroiss M; Mai K; Dekkers OM; Habra MA; Fassnacht M;

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. in European journal of endocrinology / Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.
2021
AOU San Luigi di Orbassano

Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL;

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.
2021
AOU San Luigi di Orbassano

Crona J; Baudin E; Terzolo M; Chrisoulidou A; Angelousi A; Ronchi CL; Oliveira CL; Nieveen van Dijkum EJM; Ceccato F; Borson-Chazot F; Reimondo G; Tiberi GAM; Ettaieb H; Kiriakopoulos A; Canu L; Kastelan D; Osher E; Yiannakopoulou E; Arnaldi G; Assié G; Paiva I; Bourdeau I; Newell-Price J; Nowak KM; Romero MT; De Martino MC; Bugalho MJ; Sherlock M; Vantyghem MC; et alii...

2021
AOU San Luigi di Orbassano

Giordano TJ; Berney D; de Krijger RR; Erickson L; Fassnacht M; Mete O; Papathomas T; Papotti M; Sasano H; Thompson LDR; Volante M; Gill AJ; Giordano TJ; Berney D; de Krijger RR; Erickson L; Fassnacht M; Mete O; Papathomas T; Papotti M; Sasano H; Thompson LDR; Volante M; Gill AJ;

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.
2020
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

2020
AOU San Luigi di Orbassano

Altieri B; Sbiera S; Herterich S; De Francia S; Della Casa S; Calabrese A; Pontecorvi A; Quinkler M; Kienitz T; Mannelli M; Canu L; Angelousi A; Chortis V; Kroiss M; Terzolo M; Fassnacht M; Ronchi CL;

Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa293. doi: 10.1210/clinem/dgaa293.
2020
AOU San Luigi di Orbassano

Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M;

2018
AOU San Luigi di Orbassano

Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M;

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2017 Sep 1;102(9):3491-3498. doi: 10.1210/jc.2017-00984.
2017
AOU San Luigi di Orbassano

Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E;

Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano

Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.
2014
AOU San Luigi di Orbassano

Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M; Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; et alii...

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.
2013
AOU San Luigi di Orbassano

Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.
2012
AOU San Luigi di Orbassano

Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2012 Jun 15;18(12):3452-61. doi: 10.1158/1078-0432.CCR-11-2692. Epub 2012 Apr 30.
2012
AOU San Luigi di Orbassano

Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A;